Esophoria at near is a risk factor for myopia development and progression. Does it need to be managed in an emmetropic patient without symptoms? Is this patient a pre-myope, and how should this factor into management? Read this interesting clinical case, where colleagues discuss whether to intervene or not, and how to potentially manage both myopia risk and binocular vision.
As technology evolves the next big change is likely to be Virtual Reality. Could we expect Virtual Reality to be better for myopia than our screens and smartphones of today? How will the artificially simulated visual environment of VR impact on children’s visual development? Let’s explore what we know and what we’re yet to learn.
Welcome to the final instalment of myopia content from the American Academy of Optometry 2019 meeting. These updates continue from Part 2, which detailed Mark Bullimore and Noel Brennan’s fantastic session entitled Twelve Evidence Based Things That We Should Know About Myopia.
Welcome to Part 2 of the updates from the American Academy of Optometry 2019 Meeting. These updates all sprung from Mark Bullimore and Noel Brennan’s fantastic session entitled Twelve Evidence Based Things That We Should Know About Myopia.
Latest Research from IMC2019. Could this be the solution to the screen scourge? This is mega exciting stuff – so clever and yet so simple.
Discover part 2 of the latest news from the biennial Orthokeratology Society of Oceania (OSO) conference 2018.
The annual Association for Research in Vision and Ophthalmology (ARVO) conference moved off mainland America to Hawaii for the first time in May 2018.
The session topics covered prevalence, progression and risk factors of myopia, mechanisms such as light exposure and visual pathways, optical and pharmacological methods of myopia control, genetics, clinical trial considerations, myopic eye shape and accommodation and binocularity.
Three more fascinating areas and/or pieces of research presented at IMC, and some bonus material.
